Endo Launches First US Rival To Merz’s Cuvposa
Company’s Par Unit Starts Shipping Glycopyrrolate Oral Solution
Endo’s Par Pharmaceutical has begun shipping the first generic version of Merz’s Cuvposa (glycopyrrolate) 1mg/5ml oral solution in the US following FDA approval.
You may also be interested in...
Endo still sees significant potential in Vasostrict despite the onset of competition. Meanwhile, the firm says it is focusing on “optimizing” its generics business.
ANI Pharmaceuticals has finally delivered its long-awaited launch of purified Cortrophin Gel (repository corticotropin injection) in the US, accompanying the launch with its ‘Cortrophin In Your Corner’ dedicated program to increase access and provide reimbursement support.
To extend its representation in Europe, IGBA has welcomed the generic and biosimilar drug association of Serbia and Montenegro – Genezis – to the global off-patent industry body.